DRUG · Mapped RxNorm record
Tocilizumab
Normalized identity: tocilizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis
NCT01007435
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo to tocilizumab
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Methotrexate
Normalized identity: methotrexateView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo to methotrexate
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
TocilizumabDRUG · verified · RxNorm: tocilizumab
MethotrexateDRUG · verified · RxNorm: methotrexate
Sponsors & collaborators
Hoffmann-La Rochelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01007435 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.